SlideShare verwendet Cookies, um die Funktionalität und Leistungsfähigkeit der Webseite zu verbessern und Ihnen relevante Werbung bereitzustellen. Wenn Sie diese Webseite weiter besuchen, erklären Sie sich mit der Verwendung von Cookies auf dieser Seite einverstanden. Lesen Sie bitte unsere Nutzervereinbarung und die Datenschutzrichtlinie.
SlideShare verwendet Cookies, um die Funktionalität und Leistungsfähigkeit der Webseite zu verbessern und Ihnen relevante Werbung bereitzustellen. Wenn Sie diese Webseite weiter besuchen, erklären Sie sich mit der Verwendung von Cookies auf dieser Seite einverstanden. Lesen Sie bitte unsere unsere Datenschutzrichtlinie und die Nutzervereinbarung.
Lung cancer screening using low-dose computed tomography: The Toronto experience Heidi Roberts 1 Demetris Patsios 1 Narinder Paul 1 TaeBong Chung 1 Scott Boerner 2 Thomas Waddell 3 Shafique Keshavjee 3 Gail Darling 3 Ming Tsao 2 Frances Shepherd 4 Depts. of 1 Medical Imaging, 2 Pathology, 3 Thoracic Surgery, 4 Medical Oncology - Princess Margaret Hospital / University Health Network, Toronto, ON, Canada Purpose We report our initial results from the ongoing lung cancer screening study using low-dose computed tomography (LDCT) in Toronto, Canada. Methods As part of the International Early Lung Cancer Action Project (I-ELCAP), we enrolled 400 high-risk smokers between June 2003 and November 2004. A helical CT was performed with 1.25mm overlapping slices, in low-dose technique (60mA, 120kV). Nodules found on baseline screening were followed up according to the I-ELCAP protocol: (1) no non-calcified nodules (NCN) or NCN ≤4mm or non-solid nodules ≤8 mm: annual repeat; (2) indeterminate NCN ≥5 mm or non-solid nodules ≥8 mm: 3 months follow up, (3) indeterminate non-solid nodules ≥15 mm: antibiotics and 1 month follow-up (see flowchart). Results The first 400 patients were 63 6 years old and had a smoking history of 43 25 pack-years. 186 (46.5%) were men, 214 (53.5%) were women. On baseline screening CT, 63 (16%) had no nodules, 273 had at least one NCN ≤4 mm or non-solid nodule ≤8 mm. 291 (73%) patients are invited for annual follow up CTs, one for a contrast-enhanced abdominal CT. 108 (27%) had indeterminate nodules that needed to be followed up: 6 after antibiotics and 1 month, 101 after 3 months, 1 had an immediate biopsy. 4 of the nodules followed up after 1 month had not resolved, and 4 of the solid nodules had grown after 3 months, resulting in 9 indications for CT-guided biopsies (2.3% of 400). All 9 biopsies revealed cytologic evidence of malignancy. Subsequently, surgical resection was performed in 8 patients, one patient underwent chemoradiation. Surgical resection confirmed cancer in 7 cases, but found chronic lung injury in one. Conclusion Our results confirm that LDCT identifies small, non-symptomatic lung cancers in a high risk population. Baseline low-dose CT normal or calcified nodules (any size) or nodules smaller than 5 mm solid nodules 5 mm or larger or non-solid nodules 8 mm or larger non-solid nodules 1.5 cm or larger annual follow-up screening CT antibiotics and follow-up CT in 1 month follow-up CT in 3 months n = 291 73% n = 6 n = 2 spiculated, 2.5 cm mass n = 1 immediate biopsy n = 108 / 27% n = 4 non-resolved grown stable n = 4 biopsy n = 9 cytologic evidence of malignancy surgery n = 8 n = 1 chemoradiation chronic lung injury n = 1 n = 7 cancer Summary In the first 400, we found - 8 cancers (2%) - all 8 in women - all 8 Stage I - 7 adenocarcinoma /BAC, 1 squamous cell cancer n = 101 n = 97 resolved Baseline LDCT (a) shows a solid mass in the right lower lobe (arrow), which has completely resolved after 1 month (b). b Baseline LDCT (a) shows a part-solid nodule in the right lower lobe (arrow), which is unchanged after 1 month (b). a Baseline LDCT (a) shows a solid pleura-based nodule in the left lower lobe (arrow), adjacent to an old rib fracture (b). Three months later it had grown (c). Biopsy / cytology were highly suspicious for well differentiated adenocarcinoma, wedge resection and histology showed organizing / proliferative phase acute lung injury, no evidence of malignancy. b a c b a Baseline LDCT shows a 2.5 cm spiculated mass (arrow), which was biopsied (adenocarcinoma); patient received chemoradiation. Baseline LDCT shows a 8 mm nodule (arrow), which is stable after 6 months. b a c Baseline LDCT (a) shows a lobulated left upper lobe nodule (arrow). Three months later it had grown (b). Biopsy / cytology (c) showed abnormal mucinous epithelium, surgical resection and histology confirmed mucinous bronchioloalveolar carcinoma.